Safety Information
![HCPs-arrow.png](/images/HCPs-arrow-1889537147099246-623570.png)
Log out
This page contains important safety information that you need to be aware of before and during treatment with ABRILADA (adalimumab). For complete safety information, please consult the Patient Medication Information leaflet contained in your product package.
Before using ABRILADA, talk to the doctor or pharmacist if you/your child:
For more information or to reach your Care Coach
ABRILADA ®, Pfizer Inc., owner/ Pfizer Canada ULC, Licensee
PFIZERFLEX TM, Pfizer Inc., owner/ Pfizer Canada ULC, Licensee
© 2024 Pfizer Canada ULC, Kirkland, Quebec H9J 2M5
PP-ABD-CAN-0037-EN